| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |